Paul Cacciatore
@libbyshope
Founder of Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
You might like
Astros fan in remission from ovarian cancer attends home-opener. Last April, Janie Morris learned she had stage 3 ovarian cancer. Doctors discovered it on Morris' birthday. khou.com/article/sports…
Is TapImmune’s cancer vaccine (TPIV200) the real deal? Vaccine being tested against ovarian & breast cancer. medcitynews.com/2018/03/tapimm…
medcitynews.com
Is TapImmune’s cancer vaccine the real deal? - MedCity News
A small study testing a cancer vaccine by a company who licensed the technology from the Mayo Clinic showed promising results in breast and ovarian cancer.
Stable Disease w/Tumor Shrinkage Reported in Subject 2 Following Single IP Dose of NK100 (allogeneic donor-derived natural killer (NK) cell cancer immunotherapy). ir.fatetherapeutics.com/news-releases/…
Only Certain Gynecologic Malignancies Benefit from Immunotherapy. #SGO2018 curetoday.com/articles/only-…
Women with Recurrent Ovarian Cancer Should Be Screened for Various Biomarkers. curetoday.com/articles/women…
PARP-7 Amplification Mutations Linked to Prolonged Survival in Ovarian Cancer. #SGO2018 cancernetwork.com/sgo/parp-7-amp…
Pembrolizumab (Keytruda) + pegylated liposomal doxorubicin (PLD) produced a RR of 19% & a CBR of 43% in pts w/ recur plat-resist ovarian cancer. #SGO2018 medpagetoday.com/meetingcoverag…
medpagetoday.com
Studies Seek Role for Anti-PD-1 Drugs in Gyn Cancers
Activity in resistant ovarian, mutated endometrial cancers
The Role of Fluid Flow in Ovarian Cancer Progression. technologynetworks.com/cancer-researc…
technologynetworks.com
The Role of Fluid Flow in Ovarian Cancer Progression
New research from Virginia Tech is moving physicians closer to pinpointing a predictor of ovarian cancer, which could lead to earlier diagnosis of what is know as the "silent killer."
Chlamydia Infection is Associated With Increased Risk of Ovarian Cancer. #AACR2018 aacr.org/Newsroom/Pages…
Repurposing Existing FDA-Approved (HDAC) Inhibitors May Provide New Treatment Approach for ARID1A-mutated ovcrs like ovarian clear cell cancer. wistar.org/news/press-rel…
Women Do Well Without Opioids after Gyn Surgery -- 89% drop in opioid use w/restrictive prescribing protocol. #SGO2018 medpagetoday.com/meetingcoverag…
medpagetoday.com
Women Do Well Without Opioids after Gyn Surgery
An 89% drop in opioid use with restrictive prescribing protocol
Federal funding for medical research severely short changes gynecologic oncology when cancer lethality is taken into account. #SGO2018 medpagetoday.com/meetingcoverag…
medpagetoday.com
Gyn Cancer Research Gets Short Shrift in Funding
Mortality-adjusted analysis shows huge disparity versus other cancers
Promise Seen With Frontline Pembrolizumab + Chemo in Ovarian Cancer. #SGO2018 targetedonc.com/news/promise-s…
Safety Analysis Favors Olaparib in Meta-Analysis Comparing PARP Inhibitors in Ovarian Cancer. #SGO2018 targetedonc.com/conference/sgo…
Baylor & M.D. Anderson discover a mutant protein, called p53-R175H, linked to ovarian cancer. medicalxpress.com/news/2018-03-u…
medicalxpress.com
Research uncovers a potential new strategy to fight ovarian cancer
A new discovery opens the possibility of developing a novel way to fight ovarian cancer. Researchers at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center have revealed...
PARP + PD-1/PD-L1 inhibition active in plat-resist & plat-sensitive ovarian cancer pts, w/DCR as high as 72%. #SGO medpagetoday.com/meetingcoverag…
medpagetoday.com
Targeted Combo Active in Advanced Ovarian Cancer
Response rate as high as 72% with PARP plus PD-1/PD-L1 inhibition
An Overview of Vigil Personalized Engineered Autologous Tumor Cells in Ovarian Cancer. #SGO2018 youtube.com/watch?time_con…
youtube.com
YouTube
An Overview of Vigil Personalized Engineered Autologous Tumor Cells...
Early Biomarkers Found for Patients Requiring Dose Reduction With Niraparib in Ovarian Cancer. #SGO2018 targetedonc.com/conference/sgo…
Higher Toxicity With Checkpoint Inhibitor Treatment Found in Study of Recurrent Ovarian Cancer. #SGO2018 targetedonc.com/conference/sgo…
Predicting Response to PARP Inhibitor Therapy in Ovarian Cancer. #SGO2018 targetedonc.com/conference/sgo…
United States Trends
- 1. Ole Miss 57,9 B posts
- 2. Lane Kiffin 18 B posts
- 3. Trinidad Chambliss 9.002 posts
- 4. #SugarBowl 7.172 posts
- 5. Kirby 19,5 B posts
- 6. Pete Golding 3.007 posts
- 7. #HottyToddy 6.003 posts
- 8. Indiana 117 B posts
- 9. Bobo 24,2 B posts
- 10. Gunner Stockton 4.714 posts
- 11. #CFBPlayoff 21,4 B posts
- 12. #GoDawgs 10,8 B posts
- 13. Sean McDonough 1.110 posts
- 14. Joe Judge 1.088 posts
- 15. Lucas Carneiro 1.042 posts
- 16. Rebs 3.251 posts
- 17. Branch 16,4 B posts
- 18. Lacy 5.795 posts
- 19. Saban 18,1 B posts
- 20. #GenshinSpecialProgram 11,2 B posts
Something went wrong.
Something went wrong.